Department of Ophthalmology, Saarland University Hospital and Saarland University Faculty of Medicine, Homburg, Saarland, Germany
Department of Ophthalmology, Saarland University Hospital and Saarland University Faculty of Medicine, Homburg, Saarland, Germany.
Br J Ophthalmol. 2024 May 21;108(5):646-653. doi: 10.1136/bjo-2022-323162.
BACKGROUND/AIMS: This retrospective multicentric panel study provides absolute numbers, types of and indications for corneal transplantation in Germany from 2011 to 2021 and sets them into the international context.
A questionnaire was sent to the 104 German ophthalmologic surgery departments and 93 (89%) provided their data.
The number of reported keratoplasties more than doubled from 2011 (n=4474) to 2021 (n=8998). Lamellar keratoplasties (49% posterior (n=2883), 4% anterior (n=231)) surpassed penetrating keratoplasty (PKP, 47%, n=2721) for the first time in 2014. Since 2016, Descemet's membrane endothelial keratoplasty (DMEK) has become the predominant keratoplasty procedure in Germany. Its number increased by 1.5-fold from 3850 (2016) to 5812 (2021). Main indications in 2021 were Fuchs' endothelial corneal dystrophy (FECD, 43%), pseudophakic corneal decompensation (12%), repeated keratoplasty (11%), infections (7%), keratoconus (6%) and corneal scarring (4%, others: 9%). The PKP percentage decreased from 70.2% in 2011 (n=3141) to 31.7% in 2021 (n=2853). Descemet's stripping (automated) endothelial keratoplasties (DSAEKs) decreased to 1% in 2021 (n=74). 98.6% of all posterior lamellar keratoplasties were DMEKs in Germany in 2021. The number of deep anterior lamellar keratoplasties (DALKs) remained comparable from 2011 (n=269) to 2021 (n=251, 2.8%).
Main indications for corneal transplantation in Germany (2021) were FECD and pseudophakic corneal decompensation. DMEK is by far the predominant corneal transplantation procedure since 2016 followed by PKP, whose absolute number decreased only slightly during the decade from 2011 to 2021. DALK proportions remain low, but stable, whereas DSAEK decreased annually and plays a minor role in Germany.
NCT03381794.
背景/目的:这项回顾性多中心面板研究提供了 2011 年至 2021 年德国角膜移植的绝对数量、类型和适应证,并将其置于国际背景下。
向德国 104 家眼科手术部门发送了一份问卷,其中 93 家(89%)提供了数据。
报告的角膜移植数量从 2011 年的 4474 例增加到 2021 年的 8998 例,增加了一倍多。板层角膜移植(后部 49%(n=2883),前部 4%(n=231))首次在 2014 年超过穿透性角膜移植(PKP,47%,n=2721)。自 2016 年以来,德斯梅特氏膜内皮角膜移植术(DMEK)已成为德国主要的角膜移植术。其数量从 2016 年的 3850 例增加到 2021 年的 5812 例,增加了 1.5 倍。2021 年的主要适应证为福克氏内皮角膜营养不良(FECD,43%)、白内障后角膜失代偿(12%)、复发性角膜移植(11%)、感染(7%)、圆锥角膜(6%)和角膜瘢痕(4%,其他:9%)。PKP 的比例从 2011 年的 70.2%(n=3141)下降到 2021 年的 31.7%(n=2853)。2021 年,德斯梅特氏剥离(自动)内皮角膜移植术(DSAEKs)降至 1%(n=74)。2021 年,德国所有后部板层角膜移植中,98.6%为 DMEK。2011 年至 2021 年,深层前部板层角膜移植(DALK)的数量保持不变(n=269 vs. n=251,2.8%)。
德国角膜移植的主要适应证(2021 年)为 FECD 和白内障后角膜失代偿。自 2016 年以来,DMEK 是迄今为止最主要的角膜移植术,其次是 PKP,其数量在 2011 年至 2021 年的十年间仅略有下降。DALK 的比例仍然较低,但稳定,而 DSAEK 逐年减少,在德国的作用较小。
NCT03381794。